Drug Master Files for: trabectedin
✉ Email this page to a colleague
trabectedin Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
21642 | I | II | 5/16/2008 | LONZA AG | ETH06 (TRABECTEDIN DRUG SUBSTANCE INTERMEDIATE) |
21755 | A | II | 6/23/2008 | PHARMA MAR SA | TRABECTEDIN |
22020 | I | II | 11/12/2008 | JANSSEN PHARMACEUTICA NV | TRABECTEDIN (R279741) |
27694 | A | II | 10/31/2013 | LONZA AG | ETH06 (TRABECTEDIN INTERMEDIATE) |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information